Guardant Health to Participate in the BofA Securities 2021 Healthcare Conference

Rhea-AI Summary

Guardant Health (Nasdaq: GH), a precision oncology leader, will participate in the BofA Securities 2021 Healthcare Conference. The management team is set to engage in a fireside chat on May 12 at 2:00 p.m. PT / 5:00 p.m. ET. Interested parties can access the live and archived webcast via the company’s website.

Guardant Health focuses on revolutionizing cancer care through proprietary blood tests and advanced analytics. Their innovative tests aid in early detection and treatment of cancer, aiming to improve patient outcomes while reducing healthcare costs.

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will be participating in the upcoming BofA Securities 2021 Healthcare Conference.

Guardant Health’s management is scheduled to participate in a fireside chat on Wednesday, May 12 at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company website at: www.guardanthealth.com.

About Guardant Health

Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets, and advanced analytics. The Guardant Health oncology platform leverages capabilities to drive commercial adoption, improve patient clinical outcomes, and lower healthcare costs across all stages of the cancer care continuum. Guardant Health has commercially launched liquid biopsy-based Guardant360^®, Guardant360 CDx, and GuardantOMNI^® tests for advanced stage cancer patients, and Guardant Reveal^™ test for early-stage cancer patients. These tests fuel development of its LUNAR screening program, which aims to address the needs of asymptomatic individuals eligible for cancer screening and individuals at a higher risk for developing cancer with early detection.

Source: Guardant Health, Inc.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210429005209/en/

FAQ

What is the date of Guardant Health's participation in the BofA Securities Conference?

Guardant Health will participate in the BofA Securities 2021 Healthcare Conference on May 12.

What time will Guardant Health's fireside chat take place?

The fireside chat is scheduled for May 12 at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time.

How can I access the webcast of Guardant Health's presentation?

The webcast can be accessed live and archived on the Investors section of Guardant Health's website.

What tests does Guardant Health offer for cancer detection?

Guardant Health offers tests such as Guardant360, Guardant360 CDx, GuardantOMNI, and Guardant Reveal for various stages of cancer.

What is the goal of Guardant Health's LUNAR screening program?

The LUNAR screening program aims to detect cancer early in asymptomatic individuals and those at higher risk.